Phase III and Phase IV (Post Marketing Surveillance) trials

“QA CAL offers end-to-end services for Phase I to IV clinical trials which is an integral part of drug development on drugs and medical devices.

We have competency in handling complex clinical trial designs (hormones, endogenous substances, elemental formulations and locally administered products) besides oral solids/liquid dosage forms.

Our experienced team is capable of executing complex studies in different therapeutic areas and phases across various geographies. We ensure planning and execution to ensure high quality and timely deliverable.”

1. Reporting of adverse events and serious adverse events.

2. Medical query and its resolution for protocol compliance

3. Accurate data collection and GCP compliance

4. Regulatory reporting for safety issues as per regulatory requirements